WithdrawnNot Applicable

Quality Improvement to Reduce Mortality or Severe Intracranial Hemorrhage in Neonatal Extracorporeal Life Support

Stopped: Lack of funding

0Started 2024-01-01

Plain-language summary

This is a three-year pre- and post- interventional study to assess the effectiveness of collaborative quality improvement interventions on reducing mortality and severe intracranial hemorrhage (ICH) for neonates receiving extracorporeal life support (ECLS) in China.

Who can participate

Age range1 Hour – 1 Month

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * ≤28 days of life * receive ECLS support Exclusion Criteria: * Infants with severe congenital anomalies * Infants with pre-ECLS ICH

What they're measuring

Mortality or severe intracranial hemorrhage (ICH) before discharge

Timeframe: From admission to discharge or death, an average of 3 months

Trial details

NCT IDNCT05075486

SponsorChildren's Hospital of Fudan University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-12-31

View on ClinicalTrials.gov More Extracorporeal Life Support trials